Valuation Charles River Laboratories International, Inc. Berne S.E.

Stocks

End-of-day quote Berne S.E. Other stock markets 03/07/2026			5-day change	1st Jan Change
186.01 ^CHF	+0.40%		+9.05%	-

02/07	Charles River Laboratories International Insider Sold Shares Worth $16,875,000, According to a Recent SEC Filing	MT
01/07	Argus Raises Price Target on Charles River Laboratories International to $250 From $200, Maintains Buy Rating	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	18,941	11,138	12,252	9,520	10,023	11,112	-	-
Change	-	-41.2%	10%	-22.3%	5.29%	10.86%	-	-
Enterprise Value (EV) ¹	21,366	13,616	14,622	11,565	11,946	12,926	12,500	12,121
Change	-	-36.28%	7.39%	-20.91%	3.29%	8.2%	-3.29%	-3.03%
P/E	49.4x	23.1x	25.9x	931x	-70x	37.6x	25.2x	23.2x
PBR	7.45x	3.75x	3.41x	2.75x	3.17x	3.37x	3.01x	2.74x
PEG	-	0.9x	-9.44x	-9.5x	0x	-0x	0.5x	2.69x
Capitalization / Revenue	5.35x	2.8x	2.97x	2.35x	2.5x	2.89x	2.83x	2.71x
EV / Revenue	6.04x	3.42x	3.54x	2.86x	2.98x	3.36x	3.19x	2.95x
EV / EBITDA	24.3x	13.7x	14.4x	11.6x	12.3x	13.1x	11.9x	10.8x
EV / EBIT	28.8x	16.3x	17.4x	14.3x	15x	15.9x	14.1x	12.7x
EV / FCF	40.2x	46.2x	40x	23.1x	23x	36.7x	32.1x	50.6x
FCF Yield	2.49%	2.17%	2.5%	4.34%	4.34%	2.72%	3.12%	1.98%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	7.6	9.48	9.22	0.2	-2.91	6.135	9.169	9.961
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	3,540	3,976	4,129	4,050	4,015	3,847	3,924	4,105
EBITDA ¹	879.5	990.9	1,013	996.1	971.5	989	1,051	1,118
EBIT ¹	742.1	834	838.8	805.9	793.9	814.1	885	952.9
Net income ¹	391	486.2	474.6	10.3	-144.3	285.1	417.3	447
Net Debt ¹	2,425	2,477	2,370	2,046	1,923	1,814	1,388	1,009
Reference price ²	375.34	218.92	238.84	186.16	203.66	230.69	230.69	230.69
Nbr of stocks (in thousands)	50,464	50,879	51,297	51,136	49,215	48,168	-	-
Announcement Date	16/02/22	22/02/23	14/02/24	19/02/25	18/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
LONZA GROUP AG	34.02x	5.98x	18.5x	0.96%	4.91TCr
REVOLUTION MEDICINES, INC.	-23.69x	348.44x	-22.41x	-.--%	4.02TCr
IQVIA HOLDINGS INC.	25.19x	2.79x	12.06x	-.--%	3.46TCr
BEONE MEDICINES AG	44.97x	4.49x	28.67x	-.--%	3.31TCr
CELLTRION, INC.	29.73x	7.68x	19.76x	0.42%	2.52TCr
MEDPACE HOLDINGS, INC.	32.72x	5.32x	24.23x	-.--%	1.59TCr
EUROFINS SCIENTIFIC SE	24.01x	2.04x	8.98x	1.11%	1.38TCr
IONIS PHARMACEUTICALS, INC.	-22.69x	14.88x	-22.26x	-.--%	1.35TCr
Average	18.03x	48.95x	8.44x	0.31%	2.82TCr
Weighted average by Cap.	19.39x	66.81x	9.22x	0.33%